OA12940A - Mélanges de polysaccharides dérivés d'héparine, leur préparation et les compositions pharmaceutiquesles contenant. - Google Patents

Mélanges de polysaccharides dérivés d'héparine, leur préparation et les compositions pharmaceutiquesles contenant. Download PDF

Info

Publication number
OA12940A
OA12940A OA1200500102A OA1200500102A OA12940A OA 12940 A OA12940 A OA 12940A OA 1200500102 A OA1200500102 A OA 1200500102A OA 1200500102 A OA1200500102 A OA 1200500102A OA 12940 A OA12940 A OA 12940A
Authority
OA
OAPI
Prior art keywords
heparin
methanol
added
minutes
sodium
Prior art date
Application number
OA1200500102A
Other languages
English (en)
French (fr)
Inventor
Vesna Biberovic
Luc Grondard
Pierre Mourier
Christian Viskov
Original Assignee
Yventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yventis Pharma Sa filed Critical Yventis Pharma Sa
Publication of OA12940A publication Critical patent/OA12940A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
OA1200500102A 2002-10-10 2003-10-08 Mélanges de polysaccharides dérivés d'héparine, leur préparation et les compositions pharmaceutiquesles contenant. OA12940A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0212584A FR2845686B1 (fr) 2002-10-10 2002-10-10 Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
OA12940A true OA12940A (fr) 2006-10-13

Family

ID=32039597

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200500102A OA12940A (fr) 2002-10-10 2003-10-08 Mélanges de polysaccharides dérivés d'héparine, leur préparation et les compositions pharmaceutiquesles contenant.

Country Status (35)

Country Link
EP (1) EP1556414B1 (zh)
JP (2) JP5021898B2 (zh)
CN (6) CN101812139A (zh)
AT (1) ATE548393T1 (zh)
AU (1) AU2003300161B2 (zh)
BR (1) BR0315149A (zh)
CA (1) CA2501546C (zh)
CY (1) CY1112808T1 (zh)
DK (1) DK1556414T3 (zh)
EC (1) ECSP055722A (zh)
ES (1) ES2383597T3 (zh)
FR (1) FR2845686B1 (zh)
GT (1) GT200300181A (zh)
HN (1) HN2003000312A (zh)
IL (1) IL167868A (zh)
MA (1) MA27398A1 (zh)
MX (1) MXPA05003321A (zh)
MY (1) MY142376A (zh)
NI (1) NI200300087A (zh)
NO (1) NO20052170L (zh)
NZ (1) NZ539229A (zh)
OA (1) OA12940A (zh)
PA (1) PA8584201A1 (zh)
PE (1) PE20040507A1 (zh)
PT (1) PT1556414E (zh)
RS (1) RS20050274A (zh)
RU (1) RU2332424C2 (zh)
SI (1) SI1556414T1 (zh)
SV (1) SV2004001626A (zh)
TN (1) TNSN05101A1 (zh)
TW (1) TWI332010B (zh)
UA (1) UA81925C2 (zh)
UY (1) UY28016A1 (zh)
WO (1) WO2004033503A1 (zh)
ZA (1) ZA200502787B (zh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
FR2857971B1 (fr) * 2003-07-24 2005-08-26 Aventis Pharma Sa Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
CN101495517B (zh) * 2006-05-25 2012-10-10 莫曼塔医药品有限公司 低分子量肝素及其用途
EP1994934A4 (en) 2006-12-05 2010-03-10 Glycoscience Lab Inc THERAPEUTIC AGENT AGAINST DEGENERATIVE ARTHRITIS
NZ594854A (en) 2009-02-02 2013-03-28 Otsuka Pharma Co Ltd Low-molecular polysulfated hyaluronic acid derivative and medicine containing same
EP2233145A1 (en) 2009-03-19 2010-09-29 Sanofi-Aventis A dose of AVE5026 for the treatment of venous thromboembolism in patients with severe renal impairment
EP2399592A1 (en) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin for use as an antithrombotic treatment in hip replacement surgery with improved safety in terms of clinically relevant bleedings and major bleedings
EP2399590A1 (en) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin for the prevention of a mortality and/or morbidity event in a patient undergoing major orthopaedic surgery
EP2399591A1 (en) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin for the extended prevention of a mortality and/or morbidity event in a patient having undergone hip fracture surgery
EP2399593A1 (en) 2010-06-28 2011-12-28 Aventis Pharma S.A. Semuloparin for use as an antithrombotic treatment in orthopaedic surgery with improved benefit-risk profile
JP2012046511A (ja) * 2010-07-30 2012-03-08 Otsuka Chem Co Ltd 低分子量多硫酸化ヒアルロン酸誘導体を含有する医薬
CA3020369C (en) * 2010-09-14 2019-11-26 University Of Miyazaki High purity heparin and production method therefor
WO2012055843A1 (en) 2010-10-28 2012-05-03 Aventis Pharma S.A. Semuloparin for the prevention of major venous thromboembolism in a patient undergoing major abdominal surgery
EP2446891A1 (en) 2010-10-28 2012-05-02 Aventis Pharma S.A. Semuloparin for use as an antithrombotic treatment in major abdominal surgery with improved safety in terms of clinically relevant bleedings and major bleedings
WO2012072799A1 (en) 2010-12-02 2012-06-07 Aventis Pharma S.A. New methods for the in vitro measurement of the biological activity of an ultra low molecular weight heparin sample
AR085961A1 (es) 2011-04-11 2013-11-06 Sanofi Sa Polisacaridos que poseen dos sitios de union a la antitrombina iii, metodo para prepararlos y composiciones farmaceuticas que los contienen
EP2548561A1 (en) 2011-07-22 2013-01-23 Aventis Pharma S.A. Semuloparin for improving the survival of patients with locally advanced cancer
WO2013044793A1 (zh) * 2011-09-26 2013-04-04 Xu Meiying 一种高纯度肝素苄酯盐及其制法和应用
CN102633908A (zh) * 2012-05-02 2012-08-15 雷晓刚 一种高品质超低分子量肝素的制备方法
ES2445494B1 (es) * 2012-08-02 2015-03-06 Rovi Lab Farmaceut Sa Procedimiento de obtención de heparinas de bajo y muy bajo peso molecular
US9873712B2 (en) * 2014-10-03 2018-01-23 Amphastar Pharmaceuticals, Inc. Method of purifying idraparinux sodium
EP3398971A4 (en) * 2015-12-30 2019-09-25 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. OLIGOSACCHARIDE OF SULPHATED HEPARIN AND PREPARATION METHOD AND APPLICATION THEREOF
CZ308106B6 (cs) * 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
CN110917208B (zh) * 2019-12-27 2021-02-12 浙江医院 硫酸化甘露葡萄糖醛酸六糖在防治动脉粥样硬化中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
FR2482611B1 (fr) * 1980-05-14 1986-03-07 Pharmindustrie Nouveaux polysaccharides sulfates, procedes pour leur preparation et leur utilisation comme medicaments
FR2504928A1 (fr) * 1981-04-29 1982-11-05 Choay Sa Oligosaccharides a chaines courtes possedant des proprietes biologiques, leur preparation et leurs applications en tant que medicaments
FR2584606A1 (fr) * 1985-07-12 1987-01-16 Dropic Utilisation de poly- et oligosaccharides pour l'obtention de medicaments actifs dans les pathologies du tissu conjonctif
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
ES2161615B1 (es) * 1999-07-23 2003-03-16 Rovi Lab Farmaceut Sa Composiciones de heparinas de muy bajo peso molecular.
JP4897991B2 (ja) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ 超低分子量ヘパリン組成物
FR2807043B1 (fr) * 2000-03-28 2002-11-22 Aventis Pharma Sa Composition pharmaceutique contenant des oligosaccharides, les nouveaux oligosaccharides et leur preparation
FR2811992B1 (fr) * 2000-07-21 2003-07-04 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
ECSP055722A (es) 2005-07-06
NI200300087A (es) 2012-02-02
SV2004001626A (es) 2004-03-08
EP1556414B1 (fr) 2012-03-07
FR2845686B1 (fr) 2013-08-30
HN2003000312A (es) 2005-10-20
PE20040507A1 (es) 2004-10-13
RU2005113987A (ru) 2006-01-27
AU2003300161A1 (en) 2004-05-04
CA2501546A1 (fr) 2004-04-22
GT200300181A (es) 2004-03-24
JP5389140B2 (ja) 2014-01-15
CA2501546C (fr) 2012-04-03
MA27398A1 (fr) 2005-06-01
AU2003300161B2 (en) 2009-08-27
BR0315149A (pt) 2005-08-16
ES2383597T3 (es) 2012-06-22
UA81925C2 (uk) 2008-02-25
UY28016A1 (es) 2004-04-30
MY142376A (en) 2010-11-30
FR2845686A1 (fr) 2004-04-16
PT1556414E (pt) 2012-05-21
CY1112808T1 (el) 2016-02-10
CN101817940A (zh) 2010-09-01
EP1556414A1 (fr) 2005-07-27
CN1798771A (zh) 2006-07-05
CN101812139A (zh) 2010-08-25
MXPA05003321A (es) 2005-07-05
DK1556414T3 (da) 2012-06-25
NO20052170L (no) 2005-07-07
TWI332010B (en) 2010-10-21
CN101812189A (zh) 2010-08-25
TNSN05101A1 (fr) 2007-05-14
NO20052170D0 (no) 2005-05-03
CN101812190A (zh) 2010-08-25
JP2006517185A (ja) 2006-07-20
ZA200502787B (en) 2005-10-18
TW200418882A (en) 2004-10-01
RS20050274A (en) 2007-06-04
RU2332424C2 (ru) 2008-08-27
NZ539229A (en) 2008-03-28
JP5021898B2 (ja) 2012-09-12
ATE548393T1 (de) 2012-03-15
JP2012051926A (ja) 2012-03-15
IL167868A (en) 2010-05-31
SI1556414T1 (sl) 2012-06-29
CN101810637A (zh) 2010-08-25
WO2004033503A1 (fr) 2004-04-22
PA8584201A1 (es) 2004-08-31

Similar Documents

Publication Publication Date Title
OA12940A (fr) Mélanges de polysaccharides dérivés d'héparine, leur préparation et les compositions pharmaceutiquesles contenant.
EP1307491B1 (fr) Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
EP0116801B1 (fr) Héparine dépolymérisée et supersulfatée, procédé pour sa préparation et compositions pharmaceutiques en contenant
US8071570B2 (en) Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
EP1226148B1 (fr) Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant
FR2935386A1 (fr) Nouveaux polysaccharides a activite antithrombotique comprenant une liaion covalente avec une chaine amine
EP1651677B1 (fr) Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
EP0133078A1 (fr) Oligosaccharides sulfatés, leur procédé de préparation et leur utilisation comme médicaments
WO2008113918A1 (fr) Heparines comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine, leur procede de preparation et leur utilisation
FR2548189A1 (fr) Nouveaux produits contenant des oligosaccharides, leur preparation et leurs applications biologiques et biochimiques
FR2935387A1 (fr) Hexadecasaccharides a activite antithrombotique comprenant une liaison covalente avec une chaine amine
FR2666810A1 (fr) Nouveaux 2-acrylamido-2-desoxy-3,6-anhydrohexoses et alkyl-2-acyclamido-3,6-anhydro-hexosides et procede pour les preparer.
WO2012042123A1 (fr) Polysaccharides biotinyles a activite antithrombotique et presentant une stabilite metabolique amelioree